Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 3 |
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies.
Biomedicines. 2017 Jan 4;5(1):3. doi: 10.3390/biomedicines5010003.
Biomedicines. 2017.
PMID: 28536346
Free PMC article.
Review.
Murine Tumor Models for Oncolytic Rhabdo-Virotherapy.
Falls T, Roy DG, Bell JC, Bourgeois-Daigneault MC.
Falls T, et al. Among authors: roy dg.
ILAR J. 2016;57(1):73-85. doi: 10.1093/ilar/ilv048.
ILAR J. 2016.
PMID: 27034397
Free PMC article.
Item in Clipboard
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.
Bourgeois-Daigneault MC, Roy DG, Aitken AS, El Sayes N, Martin NT, Varette O, Falls T, St-Germain LE, Pelin A, Lichty BD, Stojdl DF, Ungerechts G, Diallo JS, Bell JC.
Bourgeois-Daigneault MC, et al. Among authors: roy dg.
Sci Transl Med. 2018 Jan 3;10(422):eaao1641. doi: 10.1126/scitranslmed.aao1641.
Sci Transl Med. 2018.
PMID: 29298865
Item in Clipboard
Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer.
Martin NT, Roy DG, Workenhe ST, van den Wollenberg DJM, Hoeben RC, Mossman KL, Bell JC, Bourgeois-Daigneault MC.
Martin NT, et al. Among authors: roy dg.
Sci Rep. 2019 Feb 12;9(1):1865. doi: 10.1038/s41598-018-38385-7.
Sci Rep. 2019.
PMID: 30755678
Free PMC article.
Item in Clipboard
Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity.
Bourgeois-Daigneault MC, Roy DG, Falls T, Twumasi-Boateng K, St-Germain LE, Marguerie M, Garcia V, Selman M, Jennings VA, Pettigrew J, Amos S, Diallo JS, Nelson B, Bell JC.
Bourgeois-Daigneault MC, et al. Among authors: roy dg.
Mol Ther Oncolytics. 2016 Feb 17;3:16001. doi: 10.1038/mto.2016.1. eCollection 2016.
Mol Ther Oncolytics. 2016.
PMID: 27119116
Free PMC article.
Item in Clipboard
Magnetic targeting of oncolytic VSV-based therapies improves infection of tumor cells in the presence of virus-specific neutralizing antibodies in vitro.
Roy DG, Bell JC, Bourgeois-Daigneault MC.
Roy DG, et al.
Biochem Biophys Res Commun. 2020 Jun 4;526(3):641-646. doi: 10.1016/j.bbrc.2020.03.135. Epub 2020 Apr 2.
Biochem Biophys Res Commun. 2020.
PMID: 32248971
Item in Clipboard
Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment.
Bourgeois-Daigneault MC, St-Germain LE, Roy DG, Pelin A, Aitken AS, Arulanandam R, Falls T, Garcia V, Diallo JS, Bell JC.
Bourgeois-Daigneault MC, et al. Among authors: roy dg.
Breast Cancer Res. 2016 Aug 8;18(1):83. doi: 10.1186/s13058-016-0744-y.
Breast Cancer Res. 2016.
PMID: 27503504
Free PMC article.
Item in Clipboard
Cite
Cite